Show Stocks and Investing Publications • Thu, February 2, 2023
Yun Zhong Downgraded (TSHA) to Hold on, Feb 2nd, 2023
yun-zhong-downgraded-tsha-to-hold-on-feb-2nd-2023.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAIYun Zhong of BTIG, Downgraded "Taysha Gene Therapies, Inc." (TSHA) to Hold on, Feb 2nd, 2023.
Yun has made no other calls on TSHA in the last 4 months.
There are 11 other peers that have a rating on TSHA. Out of the 11 peers that are also analyzing TSHA, 3 agree with Yun's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Eun Yang of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $1.5 on, Wednesday, February 1st, 2023
- Michael Ulz of "Morgan Stanley" Downgraded from Buy to Hold and Held Target at $3 on, Friday, January 27th, 2023
- Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $3 on, Wednesday, November 9th, 2022
These are the ratings of the 8 analyists that currently disagree with Yun
- Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $6 on, Wednesday, February 1st, 2023
- Gil Blum of "Needham" Maintained at Strong Buy with Decreased Target to $6 on, Wednesday, February 1st, 2023
- Jack Allen of "Baird" Maintained at Buy with Decreased Target to $6 on, Wednesday, February 1st, 2023
- Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $4 on, Wednesday, February 1st, 2023
- Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy with Decreased Target to $13 on, Wednesday, February 1st, 2023
- Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $4 on, Wednesday, February 1st, 2023
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $13 on, Wednesday, February 1st, 2023
- Yanan Zhu of "Wells Fargo" Maintained at Buy with Decreased Target to $10 on, Wednesday, January 4th, 2023